
| 1W | 1M | 6M | 1Y | 5Y | |
|---|---|---|---|---|---|
| Stock | −1.0% | +5.2% | +24.6% | +14.3% | +83.2% |
| SPY | −2.3% | −4.4% | +0.3% | +10.2% | +67.3% |
Historical total returns · Dividends reinvested
Loading…
In 1 copy portfolio. See which with Premium
No company summary is available right now.
INCY Wins European Commission Nod For Skin Disease DrugYahoo Finance · 7 h ago
Natera and Incyte partner on Phase II colorectal cancer trialclinicaltrialsarena.com · 6 d ago
Buy, Sell, or Hold? Today’s Top Upgrades and Downgrades: Boston Scientific, DoorDash, GE Vernova, Honeywell Aerospace, Incyte. Intel, Reddit, Rivian Automotive, and More24/7 Wall St. · 18 d ago